Suchergebnisse - "Humphrey, John"

PubPharm (6)

1

Discovery of Potent and Selective Periphery-Restricted Quinazoline Inhibitors of the Cyclic Nucleotide Phosphodiesterase PDE1

enthalten in: Journal of medicinal chemistry | 2018

von Humphrey, J. | Movsesian, M. | Am Ende, C. | +11

2

Identification of a Potent, Highly Selective, and Brain Penetrant Phosphodiesterase 2A Inhibitor Clinical Candidate

enthalten in: Journal of medicinal chemistry | 2018

von Helal, C. | Arnold, E. | Boyden, T. | +26

3

The Discovery of a Novel Phosphodiesterase (PDE) 4B-Preferring Radioligand for Positron Emission Tomography (PET) Imaging

enthalten in: Journal of medicinal chemistry | 2017

von Zhang, L. | Chen, L. | Beck, E. | +19

4

Application of Structure-Based Design and Parallel Chemistry to Identify a Potent, Selective, and Brain Penetrant Phosphodiesterase 2A Inhibitor

enthalten in: Journal of medicinal chemistry | 2017

von Helal, C. | Arnold, E. | Boyden, T. | +24

ErratumIn: J Med Chem. 2018 Apr 26;61(8):3753. - PMID 29624389

5

Luteinizing Hormone Causes Phosphorylation and Activation of the cGMP Phosphodiesterase PDE5 in Rat Ovarian Follicles, Contributing, Together with PDE1 Activity, to the Resumption of Meiosis

enthalten in: Biology of reproduction | 2016

von Egbert, J. | Uliasz, T. | Shuhaibar, L. | +10

6

Design and selection parameters to accelerate the discovery of novel central nervous system positron emission tomography (PET) ligands and their application in the development of a novel phosphodiesterase 2A PET ligand

enthalten in: Journal of medicinal chemistry | 2013

von Zhang, L. | Villalobos, A. | Beck, E. | +14

1
[1]